Entry - #608328 - WEILL-MARCHESANI SYNDROME 2; WMS2 - OMIM
# 608328

WEILL-MARCHESANI SYNDROME 2; WMS2


Alternative titles; symbols

WEILL-MARCHESANI SYNDROME, AUTOSOMAL DOMINANT
SPHEROPHAKIA-BRACHYMORPHIA SYNDROME
MESODERMAL DYSMORPHODYSTROPHY, CONGENITAL
GLAUCOMA-LENS ECTOPIA-MICROSPHEROPHAKIA-STIFFNESS-SHORTNESS SYNDROME; GEMSS


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
15q21.1 Weill-Marchesani syndrome 2, dominant 608328 AD 3 FBN1 134797
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
GROWTH
Height
- Short stature, proportionate
- Adult male height 142-169 cm
- Adult female height 130-157 cm
Other
- Muscular build
HEAD & NECK
Head
- Brachycephaly
Face
- Maxillary hypoplasia
Eyes
- Severe myopia
- Glaucoma (in 80% of patients)
- Ectopia lentis (84%)
- Blindness
- Microspherophakia (small, spherical lens) (74%)
- Shallow anterior chamber
- Cataract (28%)
Nose
- Depressed nasal bridge
Mouth
- Narrow palate
Teeth
- Malformed teeth
- Malaligned teeth
CARDIOVASCULAR
Heart
- Cardiac anomalies (13%)
- Mitral valve insufficiency
- Aortic valve stenosis
- Pulmonary valve stenosis
- Ductus arteriosus
- Ventricular septal defect
CHEST
Ribs Sternum Clavicles & Scapulae
- Wide ribs
SKELETAL
- Joint stiffness (hands, shoulder, elbows, knees, and ankles)
- Joint limitations
Skull
- Broad skull
- Small shallow orbits
Spine
- Scoliosis
- Increased lumbar lordosis
- Narrow spinal canal
Limbs
- Thin cortices
Hands
- Broad hands
- Brachydactyly
- Broad metacarpals
- Broad phalanges
Feet
- Broad metatarsals
SKIN, NAILS, & HAIR
Skin
- Thick skin (74%)
NEUROLOGIC
Central Nervous System
- Mental retardation, mild (18%)
MISCELLANEOUS
- See (277600) for a phenotypically similar autosomal recessive form
MOLECULAR BASIS
- Caused by mutation in the fibrillin-1 gene (FBN1, 134797.0040)

TEXT

A number sign (#) is used with this entry because Weill-Marchesani syndrome-2 (WMS2) is caused by heterozygous mutation in the FBN1 gene (134797) on chromosome 15q21.

Weill-Marchesani syndrome-2 is allelic to geleophysic dysplasia-2 (614185) and acromicric dysplasia (102370), the skeletal and joint features of which overlap with WMS, as well as Marfan syndrome (154700).


Description

Weill-Marchesani syndrome is a rare connective tissue disorder characterized by short stature, brachydactyly, joint stiffness, and lens abnormalities (Faivre et al., 2002).

For a general phenotypic description and a discussion of genetic heterogeneity of WMS, see 277600.


Clinical Features

Probert (1953) described a family in which 4 sibs (3 females, 1 male) had spherophakia with brachydactyly, and one of their parents and many relatives had brachymorphism. The inheritance pattern was autosomal dominant. The authors noted the phenotypic similarities to Marfan syndrome.

Gorlin et al. (1974) reported a father and 2 children with WMS. Since the wife was short, this may be an example of backcross mating (homozygote with heterozygote). Jensen et al. (1974) referred to an affected father and daughter, and Young et al. (1986) reported affected mother and son.

Verloes et al. (1992) described an apparently autosomal dominant disorder with features resembling the autosomal recessive form of Weill-Marchesani syndrome (WMS1; 277600). Progressive joint stiffness, glaucoma, and lens dislocation occurred in 3 generations--grandfather, daughter, and grandson. The daughter was 159 cm tall, and the grandfather 169 cm tall. The grandfather had brachydactyly. Verloes et al. (1992) designated the disorder 'glaucoma-lens ectopia-microspherophakia-stiffness-shortness (GEMSS) syndrome' to distinguish it from 'classic' autosomal recessive WMS.

In a literature review of 128 cases of Weill-Marchesani syndrome, including 57 autosomal recessive cases, 50 autosomal dominant cases, and 21 sporadic cases, Faivre et al. (2003) found no significant differences in mode of inheritance for short stature, brachydactyly, thick skin, mild mental retardation (13% of all patients), myopia, or glaucoma. Some differences were found for microspherophakia (94% in AR, 74% in AD), ectopia lentis (64% in AR, 84% in AD), joint limitations (49% in AR, 77% in AD), and cardiac anomalies (39% in AR, 13% in AD). Some heterozygotes for the AR form presented with some mild clinical manifestations of the disease. However, Faivre et al. (2003) concluded that there is general clinical homogeneity despite genetic heterogeneity in WMS.


Inheritance

The transmission pattern of WMS2 in the family reported by Gorlin et al. (1974) and Faivre et al. (2003) was consistent with autosomal dominant inheritance.


Mapping

Because ectopia lentis is one of the main manifestations of WMS, Wirtz et al. (1996) proposed fibrillin-1 as a candidate gene for the disorder. They examined 2 affected families, including the one reported by Gorlin et al. (1974). In both families, evidence suggestive of linkage was obtained with markers on chromosome 15q21, with a maximum 2-point lod score of 2.11 for D15S118 at theta = 0. Immunohistochemical examination showed a decrease in fibrillin staining in the dermal-epidermal junctions and in the papillary dermis.


Molecular Genetics

In the affected family reported by Gorlin et al. (1974), Faivre et al. (2003) identified heterozygosity for a 24-bp deletion in the FBN1 gene (134797.0040) which cosegregated with the disease. No mutation in the FBN1 gene was detected in the affected family reported by Wirtz et al. (1996).


REFERENCES

  1. Faivre, L., Dollfus, H., Lyonnet, S., Alembik, Y., Megarbane, A., Samples, J., Gorlin, R. J., Alswaid, A., Feingold, J., Le Merrer, M., Munnich, A., Cormier-Daire, V. Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome. Am. J. Med. Genet. 123A: 204-207, 2003. [PubMed: 14598350, related citations] [Full Text]

  2. Faivre, L., Gorlin, R. J., Wirtz, M. K., Godfrey, M., Dagoneau, N., Samples, J. R., Le Merrer, M., Collod-Beroud, G., Boileau, C., Munnich, A., Cormier-Daire, V. In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J. Med. Genet. 40: 34-36, 2003. [PubMed: 12525539, related citations] [Full Text]

  3. Faivre, L., Megarbane, A., Alswaid, A., Zylberberg, L., Aldohayan, N., Campos-Xavier, A. B., Bacq, D., Legeai-Mallet, L., Bonaventure, J., Munnich, A., Cormier-Daire, V. Homozygosity mapping of a Weill-Marchesani syndrome locus to chromosome 19p13.3-p13.2. Hum. Genet. 110: 366-370, 2002. [PubMed: 11941487, related citations] [Full Text]

  4. Gorlin, R. J., L'Heureux, R. R., Shapiro, I. Weill-Marchesani syndrome in two generations: genetic heterogeneity or pseudodominance? J. Pediat. Ophthal. 11: 139-144, 1974.

  5. Jensen, A. D., Cross, H. E., Paton, D. Ocular complications in the Weill-Marchesani syndrome. Am. J. Ophthal. 77: 261-269, 1974. [PubMed: 4812097, related citations] [Full Text]

  6. Probert, L. A. Spherophakia with brachydactyly: comparison with Marfan's syndrome. Am. J. Ophthal. 36: 1571-1574, 1953. [PubMed: 13104565, related citations] [Full Text]

  7. Verloes, A., Hermia, J.-P., Galand, A., Koulischer, L., Dodinval, P. Glaucoma-lens ectopia-microspherophakia-stiffness-shortness (GEMSS) syndrome: a dominant disease with manifestations of Weill-Marchesani syndromes. Am. J. Med. Genet. 44: 48-51, 1992. [PubMed: 1519650, related citations] [Full Text]

  8. Wirtz, M. K., Samples, J. R., Kramer, P. L., Rust, K., Yount, J., Acott, T. S., Koler, R. D., Cisler, J., Jahed, A., Gorlin, R. J., Godfrey, M. Weill-Marchesani syndrome: possible linkage of the autosomal dominant form to 15q21.1. Am. J. Med. Genet. 65: 68-75, 1996. [PubMed: 8914744, related citations] [Full Text]

  9. Young, I. D., Fielder, A. R., Casey, T. A. Weill-Marchesani syndrome in mother and son. Clin. Genet. 30: 475-480, 1986. [PubMed: 3493095, related citations] [Full Text]


Marla J. F. O'Neill - updated : 8/22/2011
Cassandra L. Kniffin - updated : 10/3/2005
Creation Date:
Cassandra L. Kniffin : 12/8/2003
carol : 02/07/2024
alopez : 02/06/2024
terry : 09/12/2012
carol : 8/31/2011
carol : 8/31/2011
wwang : 8/23/2011
terry : 8/22/2011
wwang : 10/18/2005
wwang : 10/17/2005
ckniffin : 10/3/2005
alopez : 10/26/2004
carol : 12/12/2003
ckniffin : 12/9/2003

# 608328

WEILL-MARCHESANI SYNDROME 2; WMS2


Alternative titles; symbols

WEILL-MARCHESANI SYNDROME, AUTOSOMAL DOMINANT
SPHEROPHAKIA-BRACHYMORPHIA SYNDROME
MESODERMAL DYSMORPHODYSTROPHY, CONGENITAL
GLAUCOMA-LENS ECTOPIA-MICROSPHEROPHAKIA-STIFFNESS-SHORTNESS SYNDROME; GEMSS


ORPHA: 2084, 3449;   DO: 0050475;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
15q21.1 Weill-Marchesani syndrome 2, dominant 608328 Autosomal dominant 3 FBN1 134797

TEXT

A number sign (#) is used with this entry because Weill-Marchesani syndrome-2 (WMS2) is caused by heterozygous mutation in the FBN1 gene (134797) on chromosome 15q21.

Weill-Marchesani syndrome-2 is allelic to geleophysic dysplasia-2 (614185) and acromicric dysplasia (102370), the skeletal and joint features of which overlap with WMS, as well as Marfan syndrome (154700).


Description

Weill-Marchesani syndrome is a rare connective tissue disorder characterized by short stature, brachydactyly, joint stiffness, and lens abnormalities (Faivre et al., 2002).

For a general phenotypic description and a discussion of genetic heterogeneity of WMS, see 277600.


Clinical Features

Probert (1953) described a family in which 4 sibs (3 females, 1 male) had spherophakia with brachydactyly, and one of their parents and many relatives had brachymorphism. The inheritance pattern was autosomal dominant. The authors noted the phenotypic similarities to Marfan syndrome.

Gorlin et al. (1974) reported a father and 2 children with WMS. Since the wife was short, this may be an example of backcross mating (homozygote with heterozygote). Jensen et al. (1974) referred to an affected father and daughter, and Young et al. (1986) reported affected mother and son.

Verloes et al. (1992) described an apparently autosomal dominant disorder with features resembling the autosomal recessive form of Weill-Marchesani syndrome (WMS1; 277600). Progressive joint stiffness, glaucoma, and lens dislocation occurred in 3 generations--grandfather, daughter, and grandson. The daughter was 159 cm tall, and the grandfather 169 cm tall. The grandfather had brachydactyly. Verloes et al. (1992) designated the disorder 'glaucoma-lens ectopia-microspherophakia-stiffness-shortness (GEMSS) syndrome' to distinguish it from 'classic' autosomal recessive WMS.

In a literature review of 128 cases of Weill-Marchesani syndrome, including 57 autosomal recessive cases, 50 autosomal dominant cases, and 21 sporadic cases, Faivre et al. (2003) found no significant differences in mode of inheritance for short stature, brachydactyly, thick skin, mild mental retardation (13% of all patients), myopia, or glaucoma. Some differences were found for microspherophakia (94% in AR, 74% in AD), ectopia lentis (64% in AR, 84% in AD), joint limitations (49% in AR, 77% in AD), and cardiac anomalies (39% in AR, 13% in AD). Some heterozygotes for the AR form presented with some mild clinical manifestations of the disease. However, Faivre et al. (2003) concluded that there is general clinical homogeneity despite genetic heterogeneity in WMS.


Inheritance

The transmission pattern of WMS2 in the family reported by Gorlin et al. (1974) and Faivre et al. (2003) was consistent with autosomal dominant inheritance.


Mapping

Because ectopia lentis is one of the main manifestations of WMS, Wirtz et al. (1996) proposed fibrillin-1 as a candidate gene for the disorder. They examined 2 affected families, including the one reported by Gorlin et al. (1974). In both families, evidence suggestive of linkage was obtained with markers on chromosome 15q21, with a maximum 2-point lod score of 2.11 for D15S118 at theta = 0. Immunohistochemical examination showed a decrease in fibrillin staining in the dermal-epidermal junctions and in the papillary dermis.


Molecular Genetics

In the affected family reported by Gorlin et al. (1974), Faivre et al. (2003) identified heterozygosity for a 24-bp deletion in the FBN1 gene (134797.0040) which cosegregated with the disease. No mutation in the FBN1 gene was detected in the affected family reported by Wirtz et al. (1996).


REFERENCES

  1. Faivre, L., Dollfus, H., Lyonnet, S., Alembik, Y., Megarbane, A., Samples, J., Gorlin, R. J., Alswaid, A., Feingold, J., Le Merrer, M., Munnich, A., Cormier-Daire, V. Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome. Am. J. Med. Genet. 123A: 204-207, 2003. [PubMed: 14598350] [Full Text: https://doi.org/10.1002/ajmg.a.20289]

  2. Faivre, L., Gorlin, R. J., Wirtz, M. K., Godfrey, M., Dagoneau, N., Samples, J. R., Le Merrer, M., Collod-Beroud, G., Boileau, C., Munnich, A., Cormier-Daire, V. In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J. Med. Genet. 40: 34-36, 2003. [PubMed: 12525539] [Full Text: https://doi.org/10.1136/jmg.40.1.34]

  3. Faivre, L., Megarbane, A., Alswaid, A., Zylberberg, L., Aldohayan, N., Campos-Xavier, A. B., Bacq, D., Legeai-Mallet, L., Bonaventure, J., Munnich, A., Cormier-Daire, V. Homozygosity mapping of a Weill-Marchesani syndrome locus to chromosome 19p13.3-p13.2. Hum. Genet. 110: 366-370, 2002. [PubMed: 11941487] [Full Text: https://doi.org/10.1007/s00439-002-0689-3]

  4. Gorlin, R. J., L'Heureux, R. R., Shapiro, I. Weill-Marchesani syndrome in two generations: genetic heterogeneity or pseudodominance? J. Pediat. Ophthal. 11: 139-144, 1974.

  5. Jensen, A. D., Cross, H. E., Paton, D. Ocular complications in the Weill-Marchesani syndrome. Am. J. Ophthal. 77: 261-269, 1974. [PubMed: 4812097] [Full Text: https://doi.org/10.1016/0002-9394(74)90685-0]

  6. Probert, L. A. Spherophakia with brachydactyly: comparison with Marfan's syndrome. Am. J. Ophthal. 36: 1571-1574, 1953. [PubMed: 13104565] [Full Text: https://doi.org/10.1016/0002-9394(53)91786-3]

  7. Verloes, A., Hermia, J.-P., Galand, A., Koulischer, L., Dodinval, P. Glaucoma-lens ectopia-microspherophakia-stiffness-shortness (GEMSS) syndrome: a dominant disease with manifestations of Weill-Marchesani syndromes. Am. J. Med. Genet. 44: 48-51, 1992. [PubMed: 1519650] [Full Text: https://doi.org/10.1002/ajmg.1320440112]

  8. Wirtz, M. K., Samples, J. R., Kramer, P. L., Rust, K., Yount, J., Acott, T. S., Koler, R. D., Cisler, J., Jahed, A., Gorlin, R. J., Godfrey, M. Weill-Marchesani syndrome: possible linkage of the autosomal dominant form to 15q21.1. Am. J. Med. Genet. 65: 68-75, 1996. [PubMed: 8914744] [Full Text: https://doi.org/10.1002/(SICI)1096-8628(19961002)65:1<68::AID-AJMG11>3.0.CO;2-P]

  9. Young, I. D., Fielder, A. R., Casey, T. A. Weill-Marchesani syndrome in mother and son. Clin. Genet. 30: 475-480, 1986. [PubMed: 3493095] [Full Text: https://doi.org/10.1111/j.1399-0004.1986.tb01914.x]


Contributors:
Marla J. F. O'Neill - updated : 8/22/2011
Cassandra L. Kniffin - updated : 10/3/2005

Creation Date:
Cassandra L. Kniffin : 12/8/2003

Edit History:
carol : 02/07/2024
alopez : 02/06/2024
terry : 09/12/2012
carol : 8/31/2011
carol : 8/31/2011
wwang : 8/23/2011
terry : 8/22/2011
wwang : 10/18/2005
wwang : 10/17/2005
ckniffin : 10/3/2005
alopez : 10/26/2004
carol : 12/12/2003
ckniffin : 12/9/2003